Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217535 · ClinicalTrials.gov registry record
Rutgers University Study of the Genetics of Kidney Disease
A clinical trial of Kidney Diseases and Kidney Disease, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT07217535: Recruiting study of Kidney Diseases and Kidney Disease, sponsored by Rutgers, The State University of New Jersey.
NCT07217535 is a study of Kidney Diseases and Kidney Disease that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50,000 participants, above the 470-participant average among 38 other Kidney Diseases trials with a reported enrollment target (10538% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217535, a study of Kidney Diseases and Kidney Disease, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Primary Outcome
Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with kidney disease and/or kidney disease subtype.
Conditions Studied
Interventions
- GENETIC Saliva sample
- OTHER Health surveys
Study Locations (1)
New Jersey
- Rutgers, The State University of New Jersey - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2027-10-31 |
What NCT07217535 shows while recruiting
NCT07217535 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 470-participant average among 38 other Kidney Diseases trials with a reported enrollment target (10538% higher).
The record links to 6 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Saliva sample is the first listed.
NCT07217535 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07217535 about?
NCT07217535 is a clinical study titled "Rutgers University Study of the Genetics of Kidney Disease". The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and req...
What is the current status of trial NCT07217535?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2025-11-01. Estimated completion is 2027-10-31.
What conditions does trial NCT07217535 study?
This clinical trial studies the following conditions: Kidney Diseases, Kidney Disease, Kidney Disease, Chronic, Kidney Diseases, Chronic, Kidney Disease, End-Stage.
What interventions are being tested in trial NCT07217535?
The interventions under investigation include: Saliva sample (GENETIC), Health surveys (OTHER).
Who is sponsoring clinical trial NCT07217535?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217535 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07217535's enrollment target sits among peer trials
50,000 1st of 38 higher than 38 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI